ID: MRFR/Pharma/2185-HCR | 65 Pages | Author: Rahul Gotadki | June 2023
Middle East and Africa Diabetes Market is expected to grow USD 1.62 Billion at a CAGR 6.90% during the forcast period 2023 to 2030.On an average one in ten adult is suffering from diabetes in Middle East and Africa region. Most of the case are of Type 2 diabetes and it is growing rapidly. According to International Diabetes Federation Atlas, about 19.3% of population between 20-79 age group is diabetic in UAE and the number is almost same in Saudi Arabia, Qatar, Kuwait and Bahrain. These five nations has the highest rate of diabetes per capita which is among the top 15 countries in the world. Increasing urbanization, changing lifestyle and unhealthy eating habits are driving the growth for the market. Rising middle class group, increasing per capita income, spending on healthcare and advanced healthcare infrastructure facilities are driving the growth for the market in this region.
Study objectives of Middle East and Africa Diabetes Market:
Middle East and Africa Diabetes Market by Type
Middle East and Africa Diabetes Market has been segmented on the basis of type which comprises Type 1, Type 2, and Gestational diabetes. On the basis of test, market is segmented into Random blood sugar test, Fasting blood sugar test, Oral glucose tolerance test, Initial glucose challenge test and others. On the basis of devices, it is segmented into Blood glucose monitoring devices, Diabetes management devices, and others. On the basis of treatment market is segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery and others.
Regional Analysis of Middle East and Africa Diabetes Market:
Considering the scenario of the Middle East and African diabetes market, Saudi Arabia is believed to be the largest market for diabetes. Moreover the UAE also growing and second largest market for Middle East and Africa Diabetes. On the other hand, Egypt market is expected to grow at significant rate in the Middle East and Africa diabetes during the forecasted period. Rest of Middle East and Africa is likely to have a limited but moderate growth in the market.
Key Players for Middle East and Africa Diabetes Market:
Some of the key players in Middle East and Africa Diabetes Market are: Abbott (US), Bayer AG (Germany), Becton Dickinson and Company (US), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Roche Diabetes Care, Inc. (US), sanofi-aventis U.S. LLC (US), Ypsomed (Switzerland)
The report for Middle East and Africa Diabetes Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
|Market Size||162 Billion|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type,Test,Devices and Treatment|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Abbott (US), Bayer AG (Germany), Becton Dickinson and Company (US), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Roche Diabetes Care, Inc. (US), sanofi-aventis U.S. LLC (US), Ypsomed (Switzerland)|
|Key Market Opportunities|
|Key Market Drivers||Increasing urbanization, changing lifestyle and unhealthy eating habits are driving the growth for the market.|
Key Questions Answered
Why Choose Market Research Future?